How many years can you live taking Imatinib?

The effectiveness of Imatinib (Imatinib) and a patient's lifespan can be affected by many factors, including the type of cancer, severity of the disease, the patient's overall health, the usage and dose of Imatinib, and individual treatment response. Therefore, it is impossible to provide a fixed time period to answer the question "How many years can one live after taking imatinib". However, here is some general information for your reference:

1.Chronic myeloid leukemia (CML): Imatinib has achieved remarkable success in the treatment of CML. For patients with CML in the chronic stage, treatment with imatinib can transform the disease into a chronically managed disease, allowing patients to survive long-term. Some patients can survive on maintenance therapy with imatinib for decades, or even longer. However, the situation may be different for patients with advanced CML or other complicating factors.

2.Acute lymphocytic leukemia (ALL): Imatinib is commonly used in some ALL patients, especially if there is an abnormality in the BCR-ABL fusion gene. The length of time it takes for treatment to be successful will vary depending on the patient's condition and response to treatment.

3.Cortical renal cancer (GIST): For patients with GIST, treatment with imatinib can often significantly improve survival rates. The duration of treatment also varies based on the patient's condition and response to treatment and may take months or years.

It is important to emphasize that imatinib is usually part of long-term treatment, and patients may need to continue taking the drug to maintain disease control. During treatment, doctors will regularly monitor the patient's condition and may need to adjust dosage or take other treatment measures.

Imatinib was launched in China as early as2003. The domestic medical insurance price is about 700 yuan, and the specification is 100mg*60, since medical insurance varies greatly from place to place, please consult your local pharmacy or medical insurance bureau for specific prices. Foreign medicines are divided into original drugs and generic drugs. Original drugs are mainly Turkish original drugs, and the price is relatively high, about 3300 yuan; generic drugs are mainly Indian generic drugs, and the Indian generic drugs specifications 100mg*120 are priced at around a few hundred yuan, which is much cheaper than domestic ones. The ingredients of foreign original drugs and generic drugs are basically the same as those of domestic imatinib.